Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment

Major financial players have recently shown a significant bearish trend in Johnson & Johnson (NYSE: JNJ). An examination of options trading history for Johnson & Johnson revealed 10 unusual trades.

Upon closer inspection, it was determined that 20% of the traders adopted a bullish stance, while a notable 80% displayed bearish tendencies. Specifically, among the trades observed, 6 were puts valued at $272,347, and 4 were calls valued at $162,746.

Predicted Price Range

Given the recent trading activity, it appears that large investors are forecasting a price range for Johnson & Johnson between $130.0 and $180.0 over the past three months.

Volume & Open Interest Trends

Evaluating both volume and open interest is essential in options trading. These key indicators provide insights into the liquidity and overall investor interest in Johnson & Johnson's options at specific strike prices. The following section illustrates the variations in volume and open interest concerning both calls and puts, linked to significant trades for Johnson & Johnson, over the past 30 days.

Johnson & Johnson Call and Put Volume: 30-Day Overview

Significant Options Trades Detected:

Symbol	PUT/CALL	Trade Type	Sentiment	Exp. Date	Ask	Bid	Price	Strike Price	Total Trade Price	Open Interest	Volume
JNJ	CALL	SWEEP	BEARISH	02/21/25	$5.8	$5.55	$5.55	$145.00	$55.5K	140	102
JNJ	PUT	SWEEP	BEARISH	02/21/25	$9.85	$9.65	$9.85	$155.00	$52.2K	3.4K	105
JNJ	PUT	TRADE	BULLISH	02/21/25	$10.25	$10.0	$10.0	$155.00	$50.0K	3.4K	205
JNJ	PUT	TRADE	BEARISH	02/21/25	$9.9	$9.65	$9.9	$155.00	$49.5K	3.4K	155
JNJ	PUT	TRADE	BEARISH	02/21/25	$9.9	$9.7	$9.9	$155.00	$49.5K	3.4K	52

About Johnson & Johnson

Johnson & Johnson is the largest and most diversified healthcare company globally. The firm's operations are divided into two main areas: pharmaceuticals and medical devices. Following the divestment of its consumer business, Kenvue, in 2023, these two divisions now account for all sales. The pharmaceutical sector emphasizes therapeutic areas such as immunology, oncology, neurology, pulmonary issues, cardiology, and metabolic diseases. Notably, just over half of the company's revenue is generated in the United States.

Considering the recent trends in options trading for Johnson & Johnson, it is vital to examine the company's current standing.

Current Position of Johnson & Johnson

• Trading volume is 3,379,283, with JNJ's share price slightly down by -0.06%, currently at $146.15.
• Relative Strength Index (RSI) readings suggest the stock may be oversold.
• Upcoming earnings announcements are expected in 40 days.

Professional Analyst Ratings for Johnson & Johnson

Recently, three market analysts have provided their ratings for JNJ, resulting in a consensus target price of $177.0.

Can you turn $1000 into $1270 in just 20 days?

A professional options trader with over 20 years of experience shares a simple chart technique that indicates the optimal times to buy and sell. By following his trades, you could potentially see an average return of 27% every 20 days. Click here for access.

Maintaining their perspective, a Citigroup analyst has upheld a Buy rating on Johnson & Johnson with a price target set at $175. Meanwhile, an analyst from B of A Securities has moderated their stance to Neutral with a target price of $166. Reflecting some caution, Wolfe Research has downgraded its rating to Outperform, now targeting a price of $190.

Options trading inherently involves both high risks and the potential for greater rewards. Savvy traders often mitigate risks by continuously educating themselves, refining their strategies, and monitoring multiple indicators, while staying alert to overall market movements. To stay updated on the latest Johnson & Johnson options trades, consider using real-time alerts.

Options, Trading, Market